Posted by Michael Wonder on 14 Feb 2022
Singapore is the latest country to approve Novavax’s COVID vaccine while the U.S. reviews application
14 February 2022 - On Monday, Singapore approved the COVID vaccine from U.S. vaccine maker Novavax for adults over age 18, making the city state the latest country to give the go-ahead to Novavax's protein-based jab.
Novavax's approval in Singapore follows a string of regulatory victories for the American firm, which has racked up approvals with the World Health Organization and European Medicines Agency and individual countries like Australia, the U.K., and South Korea since late last year.
